IMA · ImageneBio, Inc.

NasdaqHealthcareBiotechnology

Imagenebio Inc Is A Clinical-Stage Biopharmaceutical Company Developing Therapeutics For Patients With Immunological, Autoimmune And Inflammatory Diseases. The Company'S Flagship Asset, Img-007, Is A Non-Depleting Anti-Ox40 Monoclonal Antibody That Binds Specifically To Ox40 Receptor On Activated T Cells To Block Receptor Binding To Ox40 Ligand (Ox40l). Img-007 Is Being Developed To Potentially Treat Multiple Autoimmune And Inflammatory Diseases And Disorders. The Company Operates In A Single Segment.

HealthcareNasdaqUSLow Float

FLOAT

9.4M

FREE FLOAT %

83%

SHARES O/S

11.4M

MARKET CAP

$47.9M

EXCHANGE

Nasdaq

COUNTRY

IMA Catalyst History

No catalysts recorded for IMA yet

Day Trader Sniper hasn't classified a publishable catalyst for IMA yet. New events appear here as they're scored.

Be early on the next IMA spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

IMA · ImageneBio, Inc.

IMA Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.